Bluesight acquires Sectyr to expand 340B audit and compliance tools for health systems
Acquiring Company
Bluesight
Acquired Company
Sectyr
AlexandriaScottsdaleHealth CareArtificial IntelligenceAnalyticsMachine LearningHealth CareDescription
Bluesight, the leading provider of Medication Intelligence™ solutions, has acquired Sectyr, a top-tier compliance and audit management platform. This acquisition expands Bluesight's portfolio to include robust 340B audit and compliance tools, reinforcing its mission of empowering healthcare organizations to ensure medication safety, compliance, and operational efficiency.
Quick answer
Bluesight is acquiring Sectyr, announced October 17, 2024. Bluesight is based in Alexandria, Virginia, United States.
- How much did Bluesight pay for Sectyr?
- The deal value was not disclosed.
- What does Bluesight do?
- Bluesight solves supply chain inefficiencies and reduces risk by using AI and machine learning to surface actionable analytics for every step of the medication lifecycle.
- Where are Bluesight and Sectyr based?
- Bluesight is based in Alexandria, Virginia, United States. Sectyr is based in Scottsdale, Arizona, United States.
- Who are the decision-makers at Bluesight?
- Fundz holds 3 contacts at Bluesight. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Analytics and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Inflection AI completes acquisition of Boundaryless to accelerate deployments of trusted enterprise AI agents (October 21, 2024)
- Amplitude completes acquisition of Command AI to enhance user assistance capabilities (October 15, 2024)
- NationsBenefits acquires Health Data Decisions to strengthen leadership in fintech and healthcare solutions (September 10, 2024)
- RadNet's DeepHealth subsidiary acquires Kheiron Medical Technologies for AI-powered diagnostic solutions (October 25, 2024)
- Egen completes acquisition of Qarik, strengthens its position as a leading Google Cloud services provider (October 24, 2024)
- Enlitic completes $5M acquisition of medical imaging provider Laitek Inc. to enhance AI-powered data standardization, $5M (October 18, 2024)
Who to call at Bluesight, and when
When Bluesight changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Bluesight raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bluesight, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bluesight. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bluesight makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Sectyr?
Sectyr was acquired by Bluesight, based in Alexandria. The deal was reported on October 17, 2024. Bluesight solves supply chain inefficiencies and reduces risk by using AI and machine learning to surface actionable analytics for every step of the medication lifecycle. Bluesight is privately held and operates in Health Care.
When did Bluesight acquire Sectyr?
Bluesight's acquisition of Sectyr was reported on October 17, 2024. Bluesight, the leading provider of Medication Intelligence™ solutions, has acquired Sectyr, a top-tier compliance and audit management platform. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sectyr do?
Sectyr® provides software solutions that help healthcare and other regulated businesses achieve and maintain Continuous Program Compliance® with ever-changing regulatory requirements. It is privately held, operating in Health Care, and is based in Scottsdale.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.